Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg Supplier in India – Healthy Inc

Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg | Supplier
Product image for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg Supplier; wholesale & institutional bulk supply.
Product Information
| Generic Name | Aluminium Hydroxide & Magnesium Trisilicate |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | NFI |
| Product Type | Tablet |
| Category | Antiulcer drugs – Antacid |
| Subcategory | Antacid |
| Active Ingredient | Aluminium Hydroxide & Magnesium Trisilicate |
| Strength | 120 mg + 250 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antiulcer drugs – Antacid |
Medicine Details & Safety
| Short Description | Healthy Inc invites B2B supply enquiries for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg from licensed wholesalers, distributors, pharmacy procurement teams and institutional buyers. Order quantities, stock status, batch details and delivery schedules are confirmed before commercial acceptance. | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Symptomatic relief and healing of erosive gastroesophageal reflux disease (GERD). 2. Treatment of gastric ulcers, duodenal ulcers, and NSAID-associated mucosal injury. | ||||||||||||||||||||||||||||||||||
| Full Description | Healthy Inc invites B2B supply enquiries for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg from licensed wholesalers, distributors, pharmacy procurement teams and institutional buyers. Order quantities, stock status, batch details and delivery schedules are confirmed before commercial acceptance. Product technical specifications
Product technical specifications
Supply channels and buyer segmentsHospital procurement teams and institutional tender buyers can submit tender specifications, required documentation and staggered delivery schedules. Wholesalers and pharmacy chains can request pack configurations and replenishment planning. PCD distributors may submit territory and commercial requirements for review.Commercial supply matrix
Inventory and batch traceabilityRequest available batch numbers, expiry details, COA and approved storage conditions for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg. Agree minimum remaining shelf life and stock rotation requirements before dispatch.Procurement and deliverySubmit purchase quantity, delivery location, buyer licence details and required documents. Confirm commercial terms, payment conditions, transport arrangements and repeat-order schedule. Stock and delivery are not guaranteed until confirmed. | ||||||||||||||||||||||||||||||||||
| Dosage Instructions | Administer orally 30 to 60 minutes before morning meals (or as prescribed for antacids, after meals and at bedtime). Swallow whole with water; do not crush or chew enteric-coated tablets. | ||||||||||||||||||||||||||||||||||
| Side Effects | Common: Headache, diarrhea, constipation, abdominal discomfort, nausea. Uncommon: Flatulence, dry mouth, dizziness, transient transaminase elevation. Rare: Hypomagnesemia, Clostridioides difficile-associated diarrhea, subacute cutaneous lupus. | ||||||||||||||||||||||||||||||||||
| Warnings and Precautions | Masking Malignancy: Symptomatic relief does not preclude presence of gastric malignancy; perform diagnostic workup if alarm symptoms exist. Long-Term Bone Density: Extended chronic use may slightly elevate risk of osteoporosis-related fractures; ensure adequate calcium and vitamin D intake. | ||||||||||||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Aluminium Hydroxide & Magnesium Trisilicate or substituted benzimidazoles / antacids. 2. Severe electrolyte imbalances (for magnesium/aluminum antacids in renal failure). 3. Concurrent administration with rilpivirine-containing products. | ||||||||||||||||||||||||||||||||||
| Drug Interactions | 1. pH-Dependent Bioavailability Drugs (Ketoconazole, Itraconazole, Iron Salts): Reduced absorption due to elevated gastric pH. 2. Clopidogrel: Potential attenuation of antiplatelet activation by certain proton pump inhibitors. 3. Digoxin & Methotrexate: Elevated serum concentrations requiring dosage monitoring. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Who can request bulk supply for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | Licensed pharmaceutical wholesalers, distributors and institutional procurement teams can submit enquiries. |
| What is the minimum order quantity for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | MOQ is confirmed according to pack configuration and order requirements. |
| Is ready stock available for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | Request current stock and batch availability before placing an order. |
| Can institutional tender requirements be supported for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | Submit tender specifications and delivery schedule for feasibility review. |
| How can I request wholesale pricing for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg? | Provide quantity, delivery location and required packaging for a quotation. |
Related Products
✚
Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg ExporterView product →
✚
Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg ManufacturerView product →
✚
Aluminum Hydroxide Gel , Magnesium Trisilicate Tablets IP 500 mg + 250 mg ExporterView product →
✚
Aluminum Hydroxide Gel , Magnesium Trisilicate Tablets IP 500 mg + 250 mg ManufacturerView product →
✚
Aluminum Hydroxide Gel , Magnesium Trisilicate Tablets IP 500 mg + 250 mg SupplierView product →
Latest Posts
✚
WHO GMP certfied Glibenclamide Metformin SR TabletsRead article →✚
WHO GMP certfied Frusemide Tablets ManufacturerRead article →✚
Folic Acid Niacinamide Tablets ManufacturerRead article →✚
WHO GMP certfied Folic Acid Tablets ManufacturerRead article →✚
WHO GMP certfied Fluconazole Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate with folic acid TabletsRead article →✚
WHO GMP certfied iron with folic acid Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate Tablets ManufacturerRead article →